Fibromyalgia is a chronic condition that causes widespread pain all over the body, fatigue and poor sleep, and it often also causes problems with mood, memory and concentration. It affects about 2% of ...

Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.

Tonmya (cyclobenzaprine HCl sublingual tablets) is now available for the treatment of adults with fibromyalgia, according to Tonix Pharmaceuticals.

Tonix Pharmaceuticals (NASDAQ:TNXP) saw its shares climb 8% on Monday after the company announced that TONMYA, its newly approved treatment for fibromyalgia, has officially launched in the U.S. and is ...

Following its FDA approval in the summer, Tonix Pharma's fibromyalgia therapy Tonmya has been launched onto the market in the US, becoming the first new drug for the painful condition in more than 16 ...

Many people with fibromyalgia describe the chronic condition as a "bad case of the flu that never goes away," because they have widespread pain, wake up with stiff muscles and experience brain fog, ...

Dear Doctors: I had muscle pain and exhaustion for two years, and no one could figure out what was wrong. A rheumatologist recently diagnosed me with fibromyalgia. I would appreciate any information ...

Fibromyalgia patients’ satisfaction with their treatment is predictable through consideration of pre-treatment, patient-specific factors, according to a study in the journal Clinical and Experimental ...

Tonmya is expected to be available in the fourth quarter of 2025. The Food and Drug Administration (FDA) has approved Tonmya ™ (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of ...

Tonix Pharmaceuticals Holding Corp. receives FDA nod for Tonmya, a breakthrough fibromyalgia treatment. Click here to find ...

Fibromyalgia is a condition that can cause various symptoms involving pain and fatigue. A rheumatologist may treat this condition alongside a full medical team. Members of the treatment team may ...

Researchers and patients are calling for the NHS to overhaul its care of fibromyalgia patients.